Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 16, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	416	157	29	35	62	61
Market Cap Growth	447.44%	434.24%	-16.81%	-42.59%	1.75%	-25.71%
Enterprise Value	420	159	27	31	61	76
Last Close Price	0.39	0.15	0.03	0.03	0.06	0.07
PE Ratio	20.48	7.79	9.34	4.73	14.94	-26.76
PS Ratio	6.04	2.77	0.86	1.10	2.43	3.36
PB Ratio	7.15	2.73	1.02	1.40	3.81	5.68
P/FCF Ratio	422.95	-38.40	-12.26	5.88	21.50	-33.08
P/OCF Ratio	82.63	-47.87	8.81	5.43	19.27	-33.73
EV/Sales Ratio	6.32	2.81	0.80	0.96	2.40	4.25
EV/EBITDA Ratio	28.35	13.14	5.25	4.94	17.86	-78.05
EV/EBIT Ratio	32.16	14.75	6.92	6.11	28.90	-33.46
EV/FCF Ratio	426.26	-38.90	-11.46	5.15	21.24	-41.82
Debt / Equity Ratio	0.20	0.20	0.13	0.11	0.15	0.38
Debt / EBITDA Ratio	0.79	0.96	0.73	0.43	0.66	-
Debt / FCF Ratio	11.85	-2.87	-1.62	0.46	0.83	-2.20
Asset Turnover	0.99	0.91	0.90	1.05	0.99	0.73
Inventory Turnover	2.91	2.69	2.16	2.97	2.95	2.31
Quick Ratio	2.06	2.04	1.39	1.73	1.15	0.61
Current Ratio	3.08	3.07	2.75	2.82	2.10	1.19
Return on Equity (ROE)	44.32%	46.47%	13.15%	43.01%	37.96%	-20.32%
Return on Assets (ROA)	12.14%	10.83%	6.52%	10.33%	5.14%	-5.79%
Return on Capital (ROIC)	15.12%	13.20%	8.15%	13.62%	7.92%	-9.50%
Earnings Yield	4.88%	12.80%	12.11%	25.18%	8.27%	-3.70%
FCF Yield	0.24%	-2.60%	-8.16%	17.00%	4.65%	-3.02%
Buyback Yield / Dilution	-2.46%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%
Total Shareholder Return	-2.46%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%

Source: S&P Capital IQ. Standard template. Financial Sources.